Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Microcirculation; Pulse wave; Peripheral resistance;
مقالات ISI ترومبوسیتمی ضروری (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Antithrombotic therapy; Bleeding;
Keywords: ترومبوسیتمی ضروری; Neutrophil-to-lymphocyte ratio; Thrombosis; Hemorrhage; Essential thrombocythemia;
Keywords: ترومبوسیتمی ضروری; AA; arachidonic acid; ADP; adenosine diphosphate; CALR; calreticulin; ET; essential thrombocythemia; HRPR; high on-treatment residual platelet reactivity; JAK; janus kinase; MEA; multiple electrode aggregometry; MPL; myeloproliferative leukemia virus onco
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Acute megakaryoblastic leukemia; Transformation;
Keywords: ترومبوسیتمی ضروری; Essential Thrombocythemia; Thrombosis; High platelet count;
Keywords: ترومبوسیتمی ضروری; Genomic profile; Essential thrombocythemia; JAK2; Genetic variants;
Keywords: ترومبوسیتمی ضروری; ASCT; allogeneic stem cell transplantation; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; GVHD; graft versus host disease; IPSS; International Prognostic Scoring System; MPN; myeloproliferative neoplasm; PMF; prima
Keywords: ترومبوسیتمی ضروری; JAK; Janus kinase; STAT; signal transducers and activators of transcription; EPOR; erythropoietin receptor; TPOR; thrombopoietin receptor; G-CSFR; granulocyte colony stimulating factor receptor; γc; common gamma chain; SCID; severe combined immunodeficie
Keywords: ترومبوسیتمی ضروری; Plateletpheresis; Thrombocytapheresis; Hyperthrombocytosis; Essential thrombocythemia; Myeloproliferative neoplasms; Hydroxyurea; Anagrelide; Interferon; Myelofibrosis; Reactive;
Keywords: ترومبوسیتمی ضروری; nowotwory mieloproliferacyjne; mutacje JAK2; mutacja JAK2 V617F; czerwienica prawdziwa; nadpÅytkowoÅÄ samoistna; Myeloproliferative neoplasm; JAK2 mutation; JAK2 V617F mutation; Polycythemia vera; Essential thrombocythemia;
Keywords: ترومبوسیتمی ضروری; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplant; BETi; bromodomain and extra terminal domain inhibitor; CR; complete remission; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; FAB; French-American-
Keywords: ترومبوسیتمی ضروری; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Pregnancy; Fetal outcome; Interferon therapy
Keywords: ترومبوسیتمی ضروری; Polycythemia vera; Essential thrombocythemia; Lipocalin 2; Thrombosis;
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Hemorrhage; Polycythemia vera; Racial; Thrombosis
Keywords: ترومبوسیتمی ضروری; Anagrelide; Antiplatelet therapy; Essential thrombocythemia; Hydroxyurea; Interferon; Polycythemia vera; Ruxolitinib
Keywords: ترومبوسیتمی ضروری; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Vascular complications
Keywords: ترومبوسیتمی ضروری; Ischemic stroke; essential thrombocythemia; JAK2 V617F mutation; antiplatelet therapy; cytoreductive therapy;
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Thrombosis; Survival; JAK2V617F; CalreticulinTrombocitemia esencial; Trombosis; Supervivencia; JAK2V617F; Calreticulina
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Anagrelide; Cardiovascular evaluation; Cardiovascular adverse events; Palpitation; Edema;
Keywords: ترومبوسیتمی ضروری; Bone marrow fibrosis; Essential thrombocythemia; Polycythemia vera; Primary myelofibrosis; Ruxolitinib
Keywords: ترومبوسیتمی ضروری; Telomerase activity; Myeloproliferative neoplasm; Essential thrombocythemia; Extreme thrombocytosis; Myelodysplastic syndrome;
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Hydroxyurea; Squamous cell carcinoma;
Keywords: ترومبوسیتمی ضروری; Deep vein thrombosis; Essential thrombocythemia; Low-dose aspirin; Placental abruption; Preeclampsia; Stillbirth;
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; MGUS; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera;
Keywords: ترومبوسیتمی ضروری; myeloproliferative neoplasm; leukemic transformation; leukemia etiology; polycythemia vera; essential thrombocythemia; primary myelofibrosis; antineoplastic agents; alkylators; hydroxyurea; radioactive phosphorous; X-ray treatment; JAK2 mutation; risk fac
Keywords: ترومبوسیتمی ضروری; Myeloproliferative neoplasms (MPN); Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Hematopoietic stem cell transplantation; Ruxolitinib;
Keywords: ترومبوسیتمی ضروری; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
Keywords: ترومبوسیتمی ضروری; Molecular response; Polycythemia vera; Essential thrombocythemia; Hydroxycarbamide;
Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms
Keywords: ترومبوسیتمی ضروری; Calreticulin; Somatic mutation; Allele burden; Myeloproliferative neoplasms; Pyrosequencing; BM; bone marrow; ddPCR; digital-droplet PCR; ET; essential thrombocythemia; MPN; myeloproliferative neoplasm; NGS; next-generation sequencing; PB; peripheral bloo
SOHO State-of-the-Art Update and Next Questions: MPN
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Midostaurin; Myelofibrosis; Myeloproliferative neoplasms; Pacritinib; Polycythemia vera; Prefibrotic; Ruxolitinib;
Actualités thérapeutiques dans les néoplasies myéloprolifératives non LMC
Keywords: ترومبوسیتمی ضروری; Myélofibrose primitive; polyglobulie de Vaquez; pronostic; thrombocytémie essentielle; traitement; Primary myelofibrosis; Polycythemia vera; prognosis; essential thrombocythemia; treatment;
Diagnostic anatomopathologique des néoplasies myéloprolifératives chroniques Ph-
Keywords: ترومبوسیتمی ضروری; Biopsie ostéo-médullaire; fibrose; maladie de Vaquez; myélofibrose primitive; pronostic; thrombocytémie essentielle; Bone marrow biopsy; fibrosis; prognosis; polycythemia vera; primary myelofibrosis; essential thrombocythemia;
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
Keywords: ترومبوسیتمی ضروری; Momelotinib; Polycythemia vera; Essential thrombocythemia; Phase 2 study;
Invited reviewRecommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology
Keywords: ترومبوسیتمی ضروری; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Diagnosis; Monitoring; Prognosis;
CALR mutation profile in Irish patients with myeloproliferative neoplasms
Keywords: ترومبوسیتمی ضروری; CALR; Essential thrombocythemia; JAK2; Myeloproliferative neoplasm; Primary myelofibrosis;
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting
Keywords: ترومبوسیتمی ضروری; (JAK2); Janus kinase 2; (MPN); myeloproliferative neoplasms; (PV); polycythemia vera; (ET); essential thrombocythemia; (PMF); Primary myelofibrosis; (CALR); calreticulin; (HRM); high resolution melting; (CML); chronic myelogenous leukemia; (Hb); hemoglobi
SÃndromes mieloproliferativos
Keywords: ترومبوسیتمی ضروری; SÃndromes mieloproliferativos; Leucemia mieloide crónica; Policitemia vera; Trombocitemia esencial; Mielofibrosis primaria; Myeloproliferative diseases; Chronic myeloid leukemia; Polycythemia vera; Essential thrombocythemia; Primary myelofibrosis;
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances
Keywords: ترومبوسیتمی ضروری; Polycythemia vera; Essential thrombocythemia; Prefibrotiy/early primary myelofibrosis; Overt primary myelofibrosis; Revision; Clinical aspects;
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; IPSET-Thrombosis; Thromboembolism; Thrombosis-free survival; Turkey
inv (4)(p13q13) in patient with essential thrombocythemia: A case report
Keywords: ترومبوسیتمی ضروری; Essential thrombocythemia; Myeloproliferative disorder; inv (4)(p13q13)
Caractéristiques clinico-biologiques des patients avec thrombocytémie essentielle en fonction de leur statut mutationnel JAK2 ou CALR : étude monocentrique de 40 patients et revue de la littérature
Keywords: ترومبوسیتمی ضروری; Mutation CALR; Mutation JAK2; Thrombocytémie essentielle; Thrombose; Syndromes myéloprolifératifsCALR mutation; JAK2 mutation; Essential thrombocythemia; Thrombosis; Myeloproliferative disorders
CALR mutations screening in wild type JAK2V617F and MPLW515K/L Brazilian myeloproliferative neoplasm patients
Keywords: ترومبوسیتمی ضروری; CALR; Myeloproliferative neoplasms; Myelofibrosis; Essential thrombocythemia; JAK2V617F
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
Keywords: ترومبوسیتمی ضروری; Splanchnic vein thrombosis; Myeloproliferative neoplasm; Bone marrow morphology; Polycythemia vera; Primary myelofibrosis; Essential thrombocythemia
Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden
Keywords: ترومبوسیتمی ضروری; Polycythemia vera; Essential thrombocythemia; Predictor; Thrombosis; Hemorrhage; Time-weighted averages;
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis
Keywords: ترومبوسیتمی ضروری; Calreticulin (CALR); Essential thrombocythemia; High-resolution melting analysis; Mutation; Myeloproliferative neoplasm;
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
Keywords: ترومبوسیتمی ضروری; Smoking; Chronic myelomonocytic stimulation; Essential thrombocythemia; Polycythemia vera; Primary myelofibrosis; Myeloproliferative neoplasms MPNs; Thrombosis; Atherosclerosis; NF-κB; JAK-STAT-signaling; IL-8;
Biologie des syndromes myéloprolifératifs : classifications diagnostiques et nouveaux marqueurs moléculaires
Keywords: ترومبوسیتمی ضروری; Syndromes myéloproliferatifs; maladie de Vaquez; thrombocytémie essentielle; myélofibrose primitive; JAK2 V617F; mutation de CALR; pronostic; Myeloproliferative neoplasms; polycythemia vera; essential thrombocythemia; primary myelofibrosis; JAK2 V617F;
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
Keywords: ترومبوسیتمی ضروری; BM; bone marrow; CALR; calreticulin; CV; cardiovascular; Epo; erythropoietin; ET; essential thrombocythemia; JAK2; Janus kinase 2; MDS; myelodysplastic syndrome; MF; myelofibrosis; MPL; myeloproliferative leukemia virus oncogene; MPN; myeloproliferative